COMUNICADO: Guerbet modifica el SPC de Dotarem(R) y confirma buena tolerancia (y 2)

(11) Herborn CU, Honold E, Wolf M, Kemper J, Kinner S, Adam G, Barkhausen J.. Clinical safety and diagnostic value of the gadolinium chelate gadoterate meglumine (Gd-DOTA). Invest Radiol. 2007 Jan;42(1):58-62.

(12) Caravan P, Ellison JJ, McMurry TJ, Lauffer RB. Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications. Chem Rev. 1999 Sep 8;99(9):2293-352

Contacto para medios: Marina Rosoff - Ruder Finn France. Tel: + 33-(0)1-56-81-15-03. E-mail: mrosoff@ruderfinn.fr